...
【24h】

Treatment of locally recurrent rectal cancer, results and prognostic factors.

机译:局部复发性直肠癌的治疗,结果和预后因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Assessment of the results and prognostic factors in patients with locally recurrent rectal cancer treated with curative intent. PATIENTS AND METHODS: Forty patients with an isolated pelvic recurrence of rectal cancer were studied retrospectively. The treatment consisted of radiotherapy alone or combined with chemotherapy and/or surgery performed between January 1992 and July 2001. Radiotherapy was given with a 3-4 fields technique (6-15MV), five times a week. The median radiation dose was 50Gy (range 25-66.6Gy). Twenty-five patients underwent salvage surgery. Five patients were treated with concomitant chemotherapy (5-fluoro-uracil/leucovorin) (5FU/LV) during the 1st and 5th week of radiotherapy. RESULTS: Twenty-two of the 40 patients were male. The local recurrence free survival after 3 and 5 years, respectively, was 49 and 39%. Male gender was the only independent factor associated with failure of local control. The 3 and 5-year overall survival of the total group was 36 and 19%, respectively, with a median survival of 26 months. CONCLUSION: In a selection of patients in the treatment of locally recurrent rectal cancer valuable local palliation if not cure, can be reached. A multimodality approach seems to offer the best chances in this threatening situation.
机译:目的:评估局部根治性直肠癌患者的治疗结果和预后因素。病人和方法:回顾性研究了40例直肠癌孤立盆腔复发的患者。该治疗包括1992年1月至2001年7月间单独进行放疗或与化学疗法和/或手术相结合。放疗采用3-4场技术(6-15MV),每周进行五次。中值辐射剂量为50Gy(范围为25-66.6Gy)。 25名患者接受了抢救手术。 5名患者在放疗的第1周和第5周接受了同时化疗(5-氟尿嘧啶/亚叶酸)(5FU / LV)的治疗。结果:40例患者中有22例为男性。 3年和5年后的局部无复发生存率分别为49%和39%。男性是与局部控制失败相关的唯一独立因素。整个组的3年和5年总生存率分别为36%和19%,中位生存期为26个月。结论:在选择治疗局部复发性直肠癌的患者中,如果不能治愈,可达到有价值的局部缓解。在这种威胁情况下,多模式方法似乎提供了最佳机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号